Wisconsin Legislative Council
ACT MEMO
One Ea st Ma in Stre e t, Suite 401 • Ma dison, W I 53703 • (608) 266-1304 • le g.council@le gis.wisconsin.gov • http://www.le gis.wisconsin.gov/lc
Prepared by: Kelly McGraw, Staff Attorney August 30, 2023
2023 Wisconsin Act 27
[2023 Senate Bill 7]
Epinephrine Delivery Systems
BACKGROUND
Wisconsin law authorizes and facilitates epinephrine use to respond to severe allergic reactions in
schools and businesses. Prior state law referred to “epinephrine auto-injectors” and “prefilled syringes.”
The statutes previously defined epinephrine auto-injector to mean a device used for the automatic
injection of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
Prior law defined prefilled syringe to mean a device that contains a dose of epinephrine, and that is used
for the manual injection of epinephrine into the human body to prevent or treat a life-threatening
allergic reaction. The prefilled syringe must be approved by the federal Food and Drug Administration
(FDA).
2023 WISCONSIN ACT 27
2023 Wisconsin Act 27 authorizes the use of an epinephrine delivery system in the same manner as
previously authorized for an epinephrine auto-injector and a prefilled syringe. The act defines
epinephrine delivery system to mean a device that contains a premeasured dose of epinephrine, and
that is used to administer epinephrine into the human body to prevent or treat a life-threatening
allergic reaction. The epinephrine delivery system must be approved by the FDA. The act also removes
references to “epinephrine auto-injector” and “prefilled syringe” in the same statutes.
Effective date: August 6, 2023
For a full history of the bill, visit the Legislature’s bill history page.
KAM:ksm